Tivic Health Systems Inc TIVC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Tivic Health Receives Approval from Institutional Review Board for ncVNS Optimization Study, Readies for Enrollment
-
Tivic Health Accelerates VNS Commercial Strategy Development
-
Tivic Health Appoints Lisa Wolf as Interim Chief Financial Officer
-
Tivic Reports Second Quarter 2024 Financial Results
-
Tivic Health to Report Q2 2024 Financial Results and Corporate Update on August 14th Via Conference Call and Webcast
-
Tivic Announces 2024 Annual Meeting of Stockholders
-
Tivic Health Expands Intellectual Property Portfolio
Trading Information
- Previous Close Price
- $0.26
- Day Range
- $0.25–0.27
- 52-Week Range
- $0.23–3.21
- Bid/Ask
- $0.25 / $0.26
- Market Cap
- $1.55 Mil
- Volume/Avg
- 71,256 / 4.9 Mil
Key Statistics
- Price/Earnings (Normalized)
- 0.06
- Price/Sales
- 0.74
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body’s own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 9
- Website
- https://www.tivichealth.com
Valuation
|
Metric
|
TIVC
|
|---|---|
Price/Earnings (Normalized) | 0.06 |
Price/Book Value | 0.38 |
Price/Sales | 0.74 |
Price/Cash Flow | — |
Price/Earnings
TIVC
Financial Strength
|
Metric
|
TIVC
|
|---|---|
Quick Ratio | 6.28 |
Current Ratio | 7.89 |
Interest Coverage | — |
Quick Ratio
TIVC
Profitability
|
Metric
|
TIVC
|
|---|---|
Return on Assets (Normalized) | −131.62% |
Return on Equity (Normalized) | −173.36% |
Return on Invested Capital (Normalized) | −160.07% |
Return on Assets
TIVC
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Zkvjhqnd | Qgkrt | $196.0 Bil | |||
| Stryker Corp
SYK
| Zsrqcsrst | Ghqkm | $133.8 Bil | |||
| Boston Scientific Corp
BSX
| Bhffnyhws | Bpcwqq | $124.5 Bil | |||
| Medtronic PLC
MDT
| Xyhdfkxpc | Rqmvxgj | $113.2 Bil | |||
| Edwards Lifesciences Corp
EW
| Smvhdmvlt | Vmqdk | $39.5 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Xvbw | Pgl | $30.2 Bil | |||
| DexCom Inc
DXCM
| Zkvmymslmd | Msxt | $27.3 Bil | |||
| Steris PLC
STE
| Nrwykqzsq | Gcrjqs | $22.8 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Xqtwbqgcx | Lgzg | $21.3 Bil | |||
| Insulet Corp
PODD
| Xsllpkbwv | Mqmlbn | $16.1 Bil |
United States